In summary, although liver metastases were associated with inferior OS and PFS in both patients treated with PD‐1 inhibitors plus chemotherapy and chemotherapy alone, the combination of anti‐PD‐1 antibodies with chemotherapy is an effective treatment option for previously untreated advanced ESCC patients with liver metastases. Here, PDCD1 is linked to esophageal squamous cell carcinoma.